{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T08:36:43Z","timestamp":1742805403681},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Spinal Muscular Atrophy (SMA), a leading genetic cause of death in infants, is an autosomal recessive neuromuscular disease characterized by progressive muscle weakness and atrophy. While early diagnosis of SMA is critical to modifying disease progression and improving outcomes, serious diagnostic delays persist. There is a need to improve SMA awareness, screening, and referral patterns.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Two online surveys, developed by Cure SMA for general pediatricians, were distributed by Medscape Education via email (September 2018,<jats:italic>n\u2009=\u2009300<\/jats:italic>, December 2019,<jats:italic>n\u2009=\u2009600<\/jats:italic>). The surveys asked about adherence to the American Academy of Pediatrics (AAP) developmental screening and surveillance guidelines, comfort with identification of early signs of neuromuscular disease (NMD), familiarity with SMA, and barriers to timely referral.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In 2018, 70.3% of survey respondents indicated comfort in identifying early signs of NMD and 67.3% noted familiarity with SMA. 52.7% correctly indicated the need for genetic testing to make a definitive diagnosis of SMA, 74.0% meet or exceed developmental screening recommendations, and 52.0% said they would immediately refer to a specialist. In 2019, with a larger sample, 73.0% adhere to developmental screening guidelines, and awareness of the genetic testing requirement for SMA was significantly lower by 7.7% (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.03). Specialist wait times emerged as a barrier to referral, with 64.2% of respondents citing wait times of 1\u20136\u2009months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Many pediatricians underutilize developmental screening tools and lack familiarity with diagnostic requirements for SMA. Continuing efforts to expand awareness and remove barriers to timely referral to SMA specialists, including reducing appointment wait times, are needed.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12887-021-02692-2","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T10:03:24Z","timestamp":1621245804000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA)"],"prefix":"10.1186","volume":"21","author":[{"given":"Mary","family":"Curry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ros\u00e1ngel","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Belter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Schroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Jarecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"issue":"1","key":"2692_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80(1):155\u201365. https:\/\/doi.org\/10.1016\/0092-8674(95)90460-3.","journal-title":"Cell."},{"issue":"3","key":"2692_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat. 2000;15(3):228\u201337. https:\/\/doi.org\/10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9.","journal-title":"Hum Mutat"},{"issue":"2","key":"2692_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.24497","volume":"51","author":"WD Arnold","year":"2015","unstructured":"Arnold WD, Kassar D, Kissel JT. Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve. 2015;51(2):157\u201367. https:\/\/doi.org\/10.1002\/mus.24497.","journal-title":"Muscle Nerve"},{"issue":"8","key":"2692_CR4","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/archneurol.2011.74","volume":"68","author":"SJ Kolb","year":"2011","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy: a timely review. Arch Neurol. 2011;68(8):979\u201384. https:\/\/doi.org\/10.1001\/archneurol.2011.74.","journal-title":"Arch Neurol"},{"issue":"4","key":"2692_CR5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","volume":"33","author":"SJ Kolb","year":"2015","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. 2015;33(4):831\u201346. https:\/\/doi.org\/10.1016\/j.ncl.2015.07.004.","journal-title":"Neurol Clin"},{"issue":"1","key":"2692_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur J Hum Genet. 2012;20(1):27\u201332. https:\/\/doi.org\/10.1038\/ejhg.2011.134 Epub 2011 Aug 3. PMID: 21811307; PMCID: PMC3234503.","journal-title":"Eur J Hum Genet"},{"issue":"239","key":"2692_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1136\/adc.45.239.33","volume":"45","author":"DF Roberts","year":"1970","unstructured":"Roberts DF, Chavez J, Court SD. The genetic component in child mortality. Arch Dis Child. 1970;45(239):33\u20138. https:\/\/doi.org\/10.1136\/adc.45.239.33.","journal-title":"Arch Dis Child"},{"issue":"5\u20136","key":"2692_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0960-8966(94)90090-6","volume":"4","author":"NH Thomas","year":"1994","unstructured":"Thomas NH, Dubowitz V. The natural history of type I (severe) spinal muscular atrophy. Neuromuscul Disord. 1994;4(5\u20136):497\u2013502. https:\/\/doi.org\/10.1016\/0960-8966(94)90090-6 PMID: 7881295.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"2692_CR9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","volume":"52","author":"K Zerres","year":"1995","unstructured":"Zerres K, Rudnik-Schoneborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995;52(5):518\u201323. https:\/\/doi.org\/10.1001\/archneur.1995.00540290108025.","journal-title":"Arch Neurol"},{"issue":"1","key":"2692_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0022-510X(96)00284-5","volume":"146","author":"K Zerres","year":"1997","unstructured":"Zerres K, Rudnik-Schoneborn S, Forrest E, Lusakowska A, Borkowska J, Hausmanowa-Petrusewicz I. A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci. 1997;146(1):67\u201372. https:\/\/doi.org\/10.1016\/S0022-510X(96)00284-5.","journal-title":"J Neurol Sci"},{"issue":"5","key":"2692_CR11","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1086\/302369","volume":"64","author":"B Wirth","year":"1999","unstructured":"Wirth B, Herz M, Wetter A, Moskau S, Hahnen E, Rudnik-Sch\u00f6neborn S, et al. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet. 1999;64(5):1340\u201356. https:\/\/doi.org\/10.1086\/302369.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2692_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","volume":"119","author":"B Wirth","year":"2006","unstructured":"Wirth B, Brichta L, Schrank B, Lochm\u00fcller H, Blick S, Baasner A, et al. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet. 2006;119(4):422\u20138. https:\/\/doi.org\/10.1007\/s00439-006-0156-7.","journal-title":"Hum Genet"},{"issue":"8","key":"2692_CR13","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073807305788","volume":"22","author":"CH Wang","year":"2007","unstructured":"Wang CH, Finkel RS, Bertini ES. Et al; participants of the international conference on SMA standard of care. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007;22(8):1027\u201349. https:\/\/doi.org\/10.1177\/0883073807305788.","journal-title":"J Child Neurol"},{"issue":"2","key":"2692_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s13311-014-0314-x","volume":"12","author":"MA Farrar","year":"2015","unstructured":"Farrar MA, Kiernan MC. The genetics of spinal muscular atrophy: Progress and challenges. Neurotherapeutics. 2015;12(2):290\u2013302. https:\/\/doi.org\/10.1007\/s13311-014-0314-x.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"2692_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/jnnp-2016-314292","volume":"88","author":"R Wadman","year":"2017","unstructured":"Wadman R, Stam M, Gijzen M, et al. Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0-4. J Neurol Neurosurg Psychiatry. 2017;88(4):365\u20137. https:\/\/doi.org\/10.1136\/jnnp-2016-314292.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"2692_CR16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/ana.20473","volume":"57","author":"KJ Swoboda","year":"2005","unstructured":"Swoboda KJ, Prior TW, Scott CB, McNaught TP, Wride MC, Reyna SP, et al. Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol. 2005;57(5):704\u201312. https:\/\/doi.org\/10.1002\/ana.20473.","journal-title":"Ann Neurol"},{"issue":"6","key":"2692_CR17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/ana.25101","volume":"82","author":"S Kolb","year":"2017","unstructured":"Kolb S, Coffey C, Yankey J, Krosschell K, Arnold W, Rutkove S, et al. Natural history of infantile-onset spinal muscular atrophy. Ann Neurol. 2017;82(6):883\u201391. https:\/\/doi.org\/10.1002\/ana.25101.","journal-title":"Ann Neurol"},{"key":"2692_CR18","unstructured":"SPINRAZA Prescribing information. Cambridge: Biogen; 2016."},{"key":"2692_CR19","volume-title":"Prescribing information","author":"ZOLGENSMA","year":"2019","unstructured":"ZOLGENSMA. Prescribing information. Bannockburn: AveXis, Inc; 2019."},{"key":"2692_CR20","volume-title":"Prescribing information","author":"EVRYSDI","year":"2020","unstructured":"EVRYSDI. Prescribing information. San Francisco: Genentech; 2020."},{"issue":"18","key":"2692_CR21","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, et al. Nusinersen versus sham control in infantile onset spinal muscular atrophy. N Engl J Med. 2017;377(18):1723\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1702752.","journal-title":"N Engl J Med"},{"issue":"18","key":"2692_CR22","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"J Mendell","year":"2017","unstructured":"Mendell J, Al Zaidy S, Shell R, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377(18):1713\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1706198.","journal-title":"N Engl J Med"},{"key":"2692_CR23","doi-asserted-by":"publisher","unstructured":"De Vivo DC, Bertini E, Swoboda KJ, et al. Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study. Neuromuscul Dis. 2019. https:\/\/doi.org\/10.1016\/j.nmd.2019.09.007.","DOI":"10.1016\/j.nmd.2019.09.007"},{"issue":"2","key":"2692_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28(2):103\u201315. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.005.","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"2692_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3233\/JND-180315","volume":"5","author":"A Pechmann","year":"2018","unstructured":"Pechmann A, Langer T, Schorling D, Stein S, Vogt S, Schara U, et al. Evaluation of children with SMA type 1 under treatment with Nusinersen within the expanded access program in Germany. J Neuromuscul Dis. 2018;5(2):135\u201343. https:\/\/doi.org\/10.3233\/JND-180315.","journal-title":"J Neuromuscul Dis."},{"key":"2692_CR26","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2147\/TCRM.S172291","volume":"15","author":"T Dangouloff","year":"2019","unstructured":"Dangouloff T, Servais L. Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives. Ther Clin Risk Manag. 2019;15:1153\u201361. https:\/\/doi.org\/10.2147\/TCRM.S172291 Published 2019 Oct 2.","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"2692_CR27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/dmcn.14412","volume":"62","author":"K Aragon-Gawinska","year":"2020","unstructured":"Aragon-Gawinska K, Daron A, Ulinici A, Vanden Brande L, Seferian A, Gidaro T, et al. Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen. Dev Med Child Neurol. 2020;62(3):310\u20134. https:\/\/doi.org\/10.1111\/dmcn.14412 Epub 2019 Dec 4. PMID: 31799720.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"2692_CR28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0729","volume":"146","author":"MA Waldrop","year":"2020","unstructured":"Waldrop MA, Karingada C, Storey MA, Powers B, Iammarino MA, Miller NF, et al. Gene therapy for spinal muscular atrophy: safety and early outcomes. Pediatrics. 2020;146(3):e20200729. https:\/\/doi.org\/10.1542\/peds.2020-0729 PMID: 32843442.","journal-title":"Pediatrics."},{"issue":"6","key":"2692_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00008480-199912000-00004","volume":"11","author":"PB Andersson","year":"1999","unstructured":"Andersson PB, Rando TA. Neuromuscular disorders of childhood. Curr Opin Pediatr. 1999;11(6):497\u2013503. Review. PubMed PMID: 10590906. https:\/\/doi.org\/10.1097\/00008480-199912000-00004.","journal-title":"Curr Opin Pediatr"},{"issue":"7","key":"2692_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/pch\/10.7.397","volume":"10","author":"J Leyenaar","year":"2005","unstructured":"Leyenaar J, Camfield P, Camfield C. A schematic approach to hypotonia in infancy. Paediatr Child Health. 2005;10(7):397\u2013400. https:\/\/doi.org\/10.1093\/pch\/10.7.397.","journal-title":"Paediatr Child Health"},{"issue":"4","key":"2692_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.pediatrneurol.2015.06.002","volume":"53","author":"C-W Lin","year":"2015","unstructured":"Lin C-W, Kalb SJ, Yeh W-S. Delay in diagnosis of spinal muscular atrophy: a systematic literature review. Pediatric Neurol. 2015;53(4):293\u2013300. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2015.06.002.","journal-title":"Pediatric Neurol"},{"issue":"2","key":"2692_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/JND-170292","volume":"5","author":"L Belter","year":"2018","unstructured":"Belter L, Cook SF, Crawford TO, et al. An overview of the Cure SMA membership database: highlights of key demographic and clinical characteristics of SMA members. J Neuromuscul Dis. 2018;5(2):167\u201376. https:\/\/doi.org\/10.3233\/JND-170292.","journal-title":"J Neuromuscul Dis"},{"key":"2692_CR33","unstructured":"Newborn Screening for Spinal Muscular Atrophy: A Summary of the Evidence and Advisory Committee Decision. HRSA Maternal and Child Health. March 13, 2018. https:\/\/www.hrsa.gov\/sites\/default\/files\/hrsa\/advisory-committees\/heritable-disorders\/rusp\/previous-nominations\/sma-consumer-summary.pdf Accessed 13 July 2020."},{"key":"2692_CR34","unstructured":"Newborn Screening for SMA. Cure SMA. https:\/\/www.curesma.org\/newborn-screening-for-sma\/ Accessed 14 Aug 2020."},{"issue":"1","key":"2692_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2288-14-62","volume":"14","author":"SK Baxter","year":"2014","unstructured":"Baxter SK, Blank L, Woods HB, Payne N, Rimmer M, Goyder E. Using logic model methods in systematic review synthesis: describing complex pathways in referral management interventions. BMC Med Res Methodol. 2014;14(1):62. https:\/\/doi.org\/10.1186\/1471-2288-14-62. PubMed PMID: 24885751; PubMed Central PMCID: PMC4028001.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2692_CR36","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1186\/s12913-018-3745-y","volume":"18","author":"J Greenwood-Lee","year":"2018","unstructured":"Greenwood-Lee J, Jewett L, Woodhouse L, Marshall DA. A categorisation of problems and solutions to improve patient referrals from primary to specialty care. BMC Health Serv Res. 2018;18(1):986. https:\/\/doi.org\/10.1186\/s12913-018-3745-y Review. PubMed PMID: 30572898; PubMed Central PMCID: PMC6302393.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"2692_CR37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ejhg.2014.147","volume":"23","author":"S Lawton","year":"2015","unstructured":"Lawton S, Hickerton C, Archibald AD, McClaren BJ, Metcalfe SA. A mixed methods exploration of families' experiences of the diagnosis of childhood spinal muscular atrophy. Eur J Hum Genet. 2015;23(5):575\u201380. https:\/\/doi.org\/10.1038\/ejhg.2014.147.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"2692_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1542\/peds.2006-1231","volume":"118","author":"Council on Children With Disabilities; Section on Developmental Behavioral Pediatrics; Committee, Bright Futures Steering; Medical Home Initiatives for Children With Special Needs Project Advisory Committee","year":"2006","unstructured":"Council on Children With Disabilities; Section on Developmental Behavioral Pediatrics; Committee, Bright Futures Steering; Medical Home Initiatives for Children With Special Needs Project Advisory Committee. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics. 2006;118(1):405\u201320 Retrieved from https:\/\/pediatrics.aappublications.org\/content\/118\/1\/405.long.","journal-title":"Pediatrics"},{"key":"2692_CR39","doi-asserted-by":"crossref","unstructured":"Noritz GH, Murphy NA. Neuromotor Screening Expert Panel. Motor Delays: Early Identification and Evaluation. Pediatrics. 2013;131(6). Available at: www.pediatrics.org\/cgi\/content\/full\/131\/6\/e2016 - September 01, 2017.","DOI":"10.1542\/peds.2013-1056"},{"key":"2692_CR40","volume-title":"Bright futures: guidelines for health supervision of infants, children, and adolescents","year":"2017","unstructured":"Hagan JF, Shaw JS, Duncan PM, editors. Bright futures: guidelines for health supervision of infants, children, and adolescents. 4th ed. Elk Grove Village: American Academy of Pediatrics; 2017.","edition":"4"},{"key":"2692_CR41","unstructured":"SMArt Moves. Cure SMA. https:\/\/smartmoves.curesma.org\/ Accessed 14 Aug 2020."},{"key":"2692_CR42","volume-title":"Ages & stages questionnaires\u00ae, third edition (ASQ\u00ae-3): a parent-completed child monitoring system","author":"J Squires","year":"2009","unstructured":"Squires J, Bricker D. Ages & stages questionnaires\u00ae, third edition (ASQ\u00ae-3): a parent-completed child monitoring system. Baltimore: Paul H. Brookes Publishing Co., Inc.; 2009."},{"key":"2692_CR43","volume-title":"Denver II: training manual","author":"WK Frankenburg","year":"1992","unstructured":"Frankenburg WK, Archer P. Denver II: training manual. 2nd ed. Denver: Denver Developmental Materials, Inc.; 1992.","edition":"2"},{"key":"2692_CR44","unstructured":"Glascoe F. Collaborating with Parents: Using Parents\u2019 Evaluation of Developmental Status (PEDS) to Detect And Address Developmental And Behavioral Problems. 2nd ed. Nolensville: PEDSTest.com, LLC; 2013."},{"issue":"1","key":"2692_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/1817-1745.181250","volume":"11","author":"MI Ahmed","year":"2016","unstructured":"Ahmed MI, Iqbal M, Hussain N. A structured approach to the assessment of a floppy neonate. J Pediatr Neurosci. 2016;11(1):2\u20136. https:\/\/doi.org\/10.4103\/1817-1745.181250.","journal-title":"J Pediatr Neurosci"},{"issue":"1","key":"2692_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/08830738050200010201","volume":"20","author":"D Rydz","year":"2005","unstructured":"Rydz D, Shevell MI, Majnemer A, Oskoui M. Developmental screening. J Child Neurol. 2005;20(1):4\u201321. https:\/\/doi.org\/10.1177\/08830738050200010201.","journal-title":"J Child Neurol"},{"issue":"9","key":"2692_CR47","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1177\/0009922811406263","volume":"50","author":"KP Marks","year":"2011","unstructured":"Marks KP, Page Glascoe F, Macias MM. Enhancing the algorithm for developmental-behavioral surveillance and screening in children 0 to 5 years. Clin Pediatr (Phila). 2011;50(9):853\u201368. https:\/\/doi.org\/10.1177\/0009922811406263.","journal-title":"Clin Pediatr (Phila)"},{"issue":"1","key":"2692_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1542\/peds.2012-0765","volume":"131","author":"JP Guevara","year":"2013","unstructured":"Guevara JP, Gerdes M, Localio R, Huang YV, Pinto-Martin J, Minkovitz CS, et al. Effectiveness of developmental screening in an urban setting. Pediatrics. 2013;131(1):30\u20137. https:\/\/doi.org\/10.1542\/peds.2012-0765.","journal-title":"Pediatrics."},{"issue":"9","key":"2692_CR49","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jamapediatrics.2014.464","volume":"168","author":"AE Carroll","year":"2014","unstructured":"Carroll AE, Bauer NS, Dugan TM, Anand V, Saha C, Downs SM. Use of a computerized decision aid for developmental surveillance and screening: a randomized clinical trial. JAMA Pediatr. 2014;168(9):815\u201321. https:\/\/doi.org\/10.1001\/jamapediatrics.2014.464.","journal-title":"JAMA Pediatr"},{"issue":"5","key":"2692_CR50","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0022-3476(87)80238-X","volume":"111","author":"JS Palfrey","year":"1987","unstructured":"Palfrey JS, Singer JD, Walker DK, Butler JA. Early identification of children\u2019s special needs: a study in five metropolitan communities. J Pediatr. 1987;111(5):651\u20139. https:\/\/doi.org\/10.1016\/S0022-3476(87)80238-X.","journal-title":"J Pediatr"},{"issue":"4","key":"2692_CR51","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/archpedi.152.4.367","volume":"152","author":"S Horwitz","year":"1998","unstructured":"Horwitz S, Leaf P, Leventhal J. 2020. Identification of psychosocial problems in pediatric primary care. Arch Pediatr Adolesc Med. 1998;152(4):367\u201371. https:\/\/doi.org\/10.1001\/archpedi.152.4.367.","journal-title":"Arch Pediatr Adolesc Med."},{"issue":"9","key":"2692_CR52","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/088307380101600904","volume":"16","author":"MI Shevell","year":"2001","unstructured":"Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M. Profile of referrals for early childhood developmental delay to ambulatory subspecialty clinics. J Child Neurol. 2001;16(9):645\u201350 https:\/\/doi.org\/10.1177\/088307380101600904.","journal-title":"J Child Neurol"},{"issue":"4","key":"2692_CR53","doi-asserted-by":"publisher","first-page":"e20190851","DOI":"10.1542\/peds.2019-0851","volume":"145","author":"PH Lipkin","year":"2020","unstructured":"Lipkin PH, Macias MM, Chen BB, Coury D, Gottschlich EA, Hyman SL, et al. Trends in Pediatricians\u2019 Developmental Screening: 2002\u20132016. Pediatrics. 2020;145(4):e20190851. https:\/\/doi.org\/10.1542\/peds.2019-0851.","journal-title":"Pediatrics"},{"issue":"10","key":"2692_CR54","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1002\/ajmg.a.36110","volume":"161A","author":"PS Kishnani","year":"2013","unstructured":"Kishnani PS, Amartino HM, Lindberg C, Miller TM, Wilson A, Keutzer J, et al. Timing of diagnosis of patients with Pompe disease: data from the Pompe registry. Am J Med Genet A. 2013;161A(10):2431\u201343. https:\/\/doi.org\/10.1002\/ajmg.a.36110.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"2692_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15844\/pedneurbriefs-29-1-4","volume":"29","author":"VK Rao","year":"2015","unstructured":"Rao VK, Kuntz NL. Delay in Diagnosis of Duchenne Muscular Dystrophy. Pediatr Neurol Briefs. 2015;29(1):5. https:\/\/doi.org\/10.15844\/pedneurbriefs-29-1-4.","journal-title":"Pediatr Neurol Briefs"},{"issue":"2","key":"2692_CR56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JND-180304","volume":"5","author":"J Glascock","year":"2018","unstructured":"Glascock J, Sampson J, Haidet-Phillips A, Connolly A, Darras B, Day J, et al. Treatment algorithm for infants diagnosed with spinal muscular atrophy through newborn screen\u00acing. J Neuromuscul Dis. 2018;5(2):145\u201358. https:\/\/doi.org\/10.3233\/JND-180304.","journal-title":"J Neuromuscul Dis."},{"issue":"2","key":"2692_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3233\/JND-190468","volume":"7","author":"J Glascock","year":"2020","unstructured":"Glascock J, Sampson J, Connolly AM, Darras BT, Day JW, Finkel R, et al. Revised recommendations for the treatment of infants diagnosed with spinal muscular atrophy via newborn screening who have 4 copies of SMN2. J Neuromuscul Dis. 2020;7(2):97\u2013100. https:\/\/doi.org\/10.3233\/JND-190468.","journal-title":"J Neuromuscul Dis."},{"key":"2692_CR58","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195125429.001.0001","volume-title":"Primary care: balancing health needs, services and technology","author":"B Starfield","year":"1998","unstructured":"Starfield B. Primary care: balancing health needs, services and technology. New York: NY Oxford University Press; 1998."},{"issue":"5","key":"2692_CR59","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/archpedi.154.5.499","volume":"154","author":"CB Forrest","year":"2000","unstructured":"Forrest CB, Glade GB, Baker AE, Bocian A, von Schrader S, Starfield B. Coordination of specialty referrals and physician satisfaction with referral care. Arch Pediatr Adolesc Med. 2000;154(5):499\u2013506. PubMed PMID: 10807303. https:\/\/doi.org\/10.1001\/archpedi.154.5.499.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"2692_CR60","doi-asserted-by":"publisher","first-page":"w555","DOI":"10.1377\/hlthaff.25.w555","volume":"25","author":"C Schoen","year":"2006","unstructured":"Schoen C, Osborn R, Huynh PT, Doty M, Peugh J, Zapert K. On the front lines of care: primary care doctors' office systems, experiences, and views in seven countries. Health Aff (Millwood). 2006;25(6):w555\u201371. Epub 2006 Nov 2. PubMed PMID: 17102164. https:\/\/doi.org\/10.1377\/hlthaff.25.w555.","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"2692_CR61","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/archinternmed.2010.480","volume":"171","author":"AS O'Malley","year":"2011","unstructured":"O'Malley AS, Reschovsky JD. Referral and consultation communication between primary care and specialist physicians: finding common ground. Arch Intern Med. 2011;171(1):56\u201365. https:\/\/doi.org\/10.1001\/archinternmed.2010.480 PubMed PMID: 21220662.","journal-title":"Arch Intern Med"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02692-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-021-02692-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02692-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:14Z","timestamp":1725062414000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-021-02692-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2692"],"URL":"https:\/\/doi.org\/10.1186\/s12887-021-02692-2","relation":{},"ISSN":["1471-2431"],"issn-type":[{"type":"electronic","value":"1471-2431"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"5 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethics approval for this study was granted by Western Institutional Review Board (WIRB). Each study qualified as exempt research by WIRB; as such WIRB waived the requirement of the informed consent for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"236"}}